Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background
NCT00162292
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
BMS-582949 and Methotrexate
Sponsor
Bristol-Myers Squibb